1
|
Nikolaidis E, Bolanos N, Anagnostopoulos D, Leivaditis V, Grapatsas K, Koletsis E, Papatriantafyllou A, Panagiotopoulos I, Mulita F, Baltayiannis N, Dahm M, Chatzimichalis A. Lung cancer invading the superior vena cava - surgical treatment. A short and up-to-date review. KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA = POLISH JOURNAL OF CARDIO-THORACIC SURGERY 2023; 20:105-110. [PMID: 37564962 PMCID: PMC10410641 DOI: 10.5114/kitp.2023.129546] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/11/2023] [Accepted: 05/15/2023] [Indexed: 08/12/2023]
Abstract
Lung cancer is one of the leading causes of cancer-related deaths worldwide. Superior vena cava syndrome (SVCS) is a rare but potentially life-threatening complication of lung cancer, occurring in approximately 5-10% of cases. There are difficulties in the process of surgical treatment of SVC infiltrated by lung tumors but the contribution of technological evolution and innovation is promising. At the same time, the amelioration of survival rates of patients subjected to surgical treatment is equally promising. The reported outcomes of surgical treatment for SVC invasion due to lung tumors vary depending on the extent of the tumor and the patient's overall health status. However, studies clearly suggest that surgical treatment can improve survival and quality of life in selected patients. The literature review showed that the surgical approach to lung cancer invading the SVC constitutes the most indispensable treatment which helps to achieve the long-term survival of patients.
Collapse
Affiliation(s)
| | - Nikolaos Bolanos
- Department of Thoracic Surgery, “Metaxa” Cancer Hospital, Piraeus, Greece
| | | | - Vasileios Leivaditis
- Department of Cardiothoracic and Vascular Surgery, Westpfal-Klinikum, Kaiserslautern, Germany
| | - Konstantinos Grapatsas
- Department of Thoracic Surgery and Thoracic Endoscopy, University Medicine Essen – Ruhrlandklinik, Essen, Germany
| | - Efstratios Koletsis
- Department of Cardiothoracic Surgery, University Hospital of Patras, Patras, Greece
| | | | | | - Francesk Mulita
- Department of Surgery, General University Hospital of Patras, Patras, Greece
| | | | - Manfred Dahm
- Department of Cardiothoracic and Vascular Surgery, Westpfal-Klinikum, Kaiserslautern, Germany
| | | |
Collapse
|
2
|
Jiang S, Hu H, Guo C, Jiang F, Liu X, Tang L, Tang J, Cheng X. Thoracic tumor resection combined with SVC replacement using autologous pericardium. World J Surg Oncol 2019; 17:227. [PMID: 31864362 PMCID: PMC6925868 DOI: 10.1186/s12957-019-1769-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2019] [Accepted: 12/12/2019] [Indexed: 11/10/2022] Open
Abstract
Background Invasion of the superior vena cava (SVC) by thoracic tumors and occurrence of SVC syndrome are often encountered in clinical practice; but the prognosis in these cases is poor. Replacement of the SVC with autologous pericardial tissue is rarely performed. In this study, we sought to investigate the postoperative outcomes of this rare procedure. Methods We performed a retrospective analysis of six patients who underwent SVC replacement using autologous pericardial tissue between October 2010 and November 2016. We collected data on the patients’ pathological features, operative characteristics, postoperative outcomes, and survival. Results All six patients were male with an average age of 52 years (range, 18–62 years). Three of the patients had lung cancer, one had stage III thymoma, and two had germinoma. Four of the six patients had mild or moderate superior vena cava compression and no corresponding clinical symptoms. The other two patients had severe compression and obvious symptoms of SVC syndrome, with the typical swelling of the face, eyelids, and upper extremities. All six patients underwent complete tumor resection, with two of the lung cancer patients undergoing right lobectomy and one undergoing right pneumonectomy. With respect to the postoperative outcomes, one patient died, whereas the others did not develop any major complications. At the end of the follow-up period, five of the patients were alive and none of the patients had developed thrombosis in the grafts. Conclusions Our findings indicated that SVC replacement with autologous pericardium is technically feasible and safe, with few postoperative complications and favorable long-term effects. Although it has some limitations, this method appears to be useful in achieving SVC reconstruction of moderate size. SVC replacement with autologous pericardium appears to have the potential for widespread clinical use.
Collapse
Affiliation(s)
- Sicong Jiang
- Department of Thoracic Surgery, Medical College of Nanchang University, Nanchang, 330000, Jiangxi, China.,Department of Thoracic Surgery, Jiangxi Province Tumor Hospital, No. 519 Beijing east Road, Nanchang, 330006, Jiangxi, China
| | - Hao Hu
- Department of Thoracic Surgery, Medical College of Nanchang University, Nanchang, 330000, Jiangxi, China
| | - Changying Guo
- Department of Thoracic Surgery, Jiangxi Province Tumor Hospital, No. 519 Beijing east Road, Nanchang, 330006, Jiangxi, China
| | - Feng Jiang
- Department of Thoracic Surgery, Jiangxi Province Tumor Hospital, No. 519 Beijing east Road, Nanchang, 330006, Jiangxi, China
| | - Xi Liu
- Department of Thoracic Surgery, Jiangxi Province Tumor Hospital, No. 519 Beijing east Road, Nanchang, 330006, Jiangxi, China
| | - Lang Tang
- Department of Thoracic Surgery, Jiangxi Province Tumor Hospital, No. 519 Beijing east Road, Nanchang, 330006, Jiangxi, China
| | - Jianjun Tang
- Department of Thoracic Surgery, Jiangxi Province Tumor Hospital, No. 519 Beijing east Road, Nanchang, 330006, Jiangxi, China. .,Department of Oncology, The Fifth Affiliated Hospital of Sun Yat-sen University, No. 52 Mei hua east Road, Zhuhai, 519000, Guangdong, China.
| | - Xiaoliang Cheng
- Department of Thoracic Surgery, Jiangxi Province Tumor Hospital, No. 519 Beijing east Road, Nanchang, 330006, Jiangxi, China.
| |
Collapse
|